1 link tagged with all of: openevidence + physician adoption + venture funding
Click any tag below to further narrow down your results
Links
OpenEvidence, an AI clinical search tool used by 40% of US physicians, raised $250 million at a $15 billion valuation — a 25% jump from January — and is now considering acquisition offers instead of going public. The company's hitting roughly $300 million in annual revenue.
- OpenEvidence closed a $250M funding round at $15B valuation, doubling its January $12B mark in nine months
- The company commands 40% of the US physician market and generated ~$300M annualized revenue by mid-2026
- Founders are actively exploring acquisition interest rather than pursuing an IPO path